Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 456

1.

Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.

Zhang Z, Pang Y, Wang Y, Liu C, Zhao Y.

Int J Antimicrob Agents. 2014 Mar;43(3):231-5. doi: 10.1016/j.ijantimicag.2013.12.007. Epub 2013 Dec 31.

PMID:
24439458
2.

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, Deng G, Tu S, Liu W.

BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315.

3.

Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Zhang Z, Lu J, Liu M, Wang Y, Qu G, Li H, Wang J, Pang Y, Liu C, Zhao Y.

J Infect. 2015 Apr;70(4):335-45. doi: 10.1016/j.jinf.2014.11.008. Epub 2014 Dec 5.

PMID:
25485999
4.
5.

Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.

Wang XH, Ma AG, Han XX, Gu XM, Fu LP, Li PG, Li FY, Wang QZ, Liang H, Katar A, Wang LJ.

Med Sci Monit. 2015 May 7;21:1313-8. doi: 10.12659/MSM.892951.

6.

Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.

Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

J Clin Microbiol. 2012 Sep;50(9):2857-62. doi: 10.1128/JCM.00358-12. Epub 2012 May 30.

7.

Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.

Zhang J, Mi L, Wang Y, Liu P, Liang H, Huang Y, Lv B, Yuan L.

BMC Res Notes. 2012 Jun 19;5:309. doi: 10.1186/1756-0500-5-309.

9.

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.

Hu Y, Zhao Q, Werngren J, Hoffner S, Diwan VK, Xu B.

BMC Infect Dis. 2016 Jan 7;16:4. doi: 10.1186/s12879-015-1331-z.

10.

Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Surcouf C, Heng S, Pierre-Audigier C, Cadet-Daniel V, Namouchi A, Murray A, Gicquel B, Guillard B.

BMC Infect Dis. 2011 Sep 28;11:255. doi: 10.1186/1471-2334-11-255.

11.

Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.

Ahmed I, Jabeen K, Inayat R, Hasan R.

Antimicrob Agents Chemother. 2013 Jun;57(6):2522-5. doi: 10.1128/AAC.02020-12. Epub 2013 Mar 18.

12.

Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.

Zhang Z, Liu M, Wang Y, Pang Y, Kam KM, Zhao Y.

Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1959-66. doi: 10.1007/s10096-014-2144-5. Epub 2014 Jun 7.

PMID:
24906439
13.

[Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].

Wang JJ, Hu Y, Jiang WL, Wang WB, Xu B.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Nov;30(11):1189-93. Chinese.

PMID:
20193593
14.

Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.

Mokrousov I, Vyazovaya A, Solovieva N, Sunchalina T, Markelov Y, Chernyaeva E, Melnikova N, Dogonadze M, Starkova D, Vasilieva N, Gerasimova A, Kononenko Y, Zhuravlev V, Narvskaya O.

BMC Microbiol. 2015 Dec 18;15:279. doi: 10.1186/s12866-015-0613-3.

15.

Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China.

Luo T, Zhao M, Li X, Xu P, Gui X, Pickerill S, DeRiemer K, Mei J, Gao Q.

Antimicrob Agents Chemother. 2010 Mar;54(3):1075-81. doi: 10.1128/AAC.00964-09. Epub 2009 Dec 14.

16.

In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.

Zhang Z, Li T, Qu G, Pang Y, Zhao Y.

Int J Antimicrob Agents. 2015 Jan;45(1):71-5. doi: 10.1016/j.ijantimicag.2014.09.012. Epub 2014 Oct 18.

PMID:
25459737
18.

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.

Yu XL, Wen ZL, Chen GZ, Li R, Ding BB, Yao YF, Li Y, Wu H, Guo XK, Wang HH, Zhang SL.

J Antibiot (Tokyo). 2014 Apr;67(4):291-7. doi: 10.1038/ja.2013.133. Epub 2013 Dec 11.

PMID:
24326341
19.

Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.

Gandhi NR, Brust JC, Moodley P, Weissman D, Heo M, Ning Y, Moll AP, Friedland GH, Sturm AW, Shah NS.

Emerg Infect Dis. 2014 Mar;20(3):426-33. doi: 10.3201/eid2003.131083.

20.

Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.

Perdigão J, Macedo R, João I, Fernandes E, Brum L, Portugal I.

Microb Drug Resist. 2008 Jun;14(2):133-43. doi: 10.1089/mdr.2008.0798.

PMID:
18573039
Items per page

Supplemental Content

Write to the Help Desk